Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Gimeracil is an inhibitor of dihydropyrimidine dehydrogenase (DYPD; Ki = 0.36 µM), the rate limiting enzyme in the catabolism of pyrimidines, including 5-fluorouracil (5-FU; Item No. 14416).1 It inhibits the degradation of 5-FU in rat liver extracts (IC50 = 0.1 µM). Gimeracil inhibits homologous recombination and enhances radiation-induced cell death in DLD-1 human colorectal cancer cells.2 Formulations containing gimeracil have been used in conjunction with 5-fluorouracil in the treatment of various cancers.
WARNING This product is not for human or veterinary use.
1. Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-
2. Gimeracil, an inhibitor of dihydropyrimidine dehydrogenase, inhibits the early step in homologous recombination. Cancer Sci. 102(9), 1712-1716 (2011).